In the United States, Diastat (diazepam rectal gel), marketed by Valeant Pharmaceuticals, is the only FDA-approved, acute, outpatient treatment for patients ...
That's why she never leaves home without Diastat, a gel suppository that anyone can administer. Diastat is used to treat episodes of seizure attacks, ...
Barr will have the right to market generic versions of Diastat and Diastat acudial starting Sept. 1, 2010, or earlier under certain conditions. ...
Valeant holds the patent for Diastat, a gel suppository. Under the deal, Barr will have the right to launch a generic version of Diastat and Diastat AcuDial ...
Barr will have the right to market generic versions of Diastat and Diastat AcuDial starting Sept. 1, 2010, or earlier under certain conditions. ...
The Woodcliff Lake, New Jersey-based Par is entitled under the settlement to introduce a generic version of Diastat and Diastat AcuDial through its ...
Under the agreement, Barr will have the right to launch a generic version of Diastat and Diastat AcuDial on or after Sept. 1, 2010. ...
Par Pharmaceutical and Barr Pharmaceuticals have settled with Valeant Pharmaceuticals over patent litigation related to Valeant’s Diastat epilepsy products. ...
Barr will have the right to market generic versions of Diastat and Diastat AcuDial starting Sept. 1, 2010, or earlier under certain conditions. ...
N: Quote, Profile, Research) reached a settlement over their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's Diastat ...